A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 (ASP9785) vs. Bicalutamide in Castrate Men with Metastatic Prostate Cancer

Update Il y a 4 ans
Reference: EUCTR2010-021868-15

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To determine the PFS of MDV3100 as compared to bicalutamide


Inclusion criteria

  • metastatic prostate cancer